Ozempic vs. Wegovy: Same Drug, Different Price — Which Should You Get?

Ozempic and Wegovy contain the exact same molecule: semaglutide. Same manufacturer (Novo Nordisk). Same injection method. Same mechanism of action. Yet one costs differently, has different insurance coverage, and is approved for a different condition. If you are confused about which one to ask for, you are not alone — and the confusion is largely by design. This guide makes the choice simple.

The Complete Comparison Table

The Key Difference: Dose Ceiling

The single most clinically relevant difference is the maximum dose. Ozempic tops out at 2.0 mg/week, while Wegovy goes to 2.4 mg/week. The STEP clinical trial data that demonstrated 14.9% body weight loss used the 2.4 mg dose — a dose that is only FDA-approved under the Wegovy label.

In practice, many patients achieve excellent results at 1.0–2.0 mg. The additional 0.4 mg provides incremental benefit for patients who need maximum pharmacological support. If your clinician determines you need the full 2.4 mg dose, Wegovy is the technically correct prescription. For most patients at 1.0–2.0 mg, both products deliver identical results. For an even more effective option, explore tirzepatide (dual GLP-1/GIP agonist).

The Insurance Hack: Why Doctors Prescribe Ozempic for Weight Loss

Here is the open secret: millions of Ozempic prescriptions are written off-label for weight loss because insurance covers Ozempic (diabetes indication) far more readily than Wegovy (weight loss indication). If a patient has prediabetes, insulin resistance, or type 2 diabetes alongside obesity, Ozempic becomes the path of least insurance resistance.

This is medically legitimate — the patient genuinely has a condition Ozempic treats. But it contributes to Ozempic shortages and leaves patients who need it for diabetes unable to fill their prescriptions.

The Third Option: Compounded Semaglutide

Both Ozempic and Wegovy suffer from the same limitations: high cost, insurance complexity, and chronic supply shortages. Compounded semaglutide bypasses all three:

• Same molecule at a fraction of the cost
• No insurance required — HSA/FSA accepted
• Custom dose flexibility beyond FDA pen increments
• Stable supply from dedicated 503A pharmacies

Frequently Asked Questions

Are Ozempic and Wegovy really the same drug?

Yes. Both contain semaglutide manufactured by Novo Nordisk. The difference is the FDA-approved indication (diabetes vs. weight management) and the maximum available dose (2.0 mg vs. 2.4 mg).

Can my doctor prescribe Ozempic for weight loss?

Yes. Off-label prescribing is legal and common. However, if your insurance discovers the prescription is for weight loss rather than diabetes, they may deny coverage. Learn about alternatives without insurance.

Which one produces more weight loss?

At equivalent doses, they produce identical weight loss. The 2.4 mg Wegovy dose produces slightly more than the 2.0 mg Ozempic maximum due to the higher dose, not a different molecule.